Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / COM
-
Number of holders
-
11
-
Total 13F shares, excl. options
-
232K
-
Shares change
-
+232K
-
Total reported value, excl. options
-
$1.13M
-
Value change
-
+$1.13M
-
Number of buys
-
11
-
Price
-
$4.86
Significant Holders of Predictive Oncology Inc. - COM (POAI) as of Q2 2023
11 filings reported holding POAI - Predictive Oncology Inc. - COM as of Q2 2023.
Predictive Oncology Inc. - COM (POAI) has 11 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 232K shares
.
Largest 10 shareholders include VANGUARD GROUP INC (141K shares), GEODE CAPITAL MANAGEMENT, LLC (32.3K shares), RB Capital Management, LLC (20.8K shares), RENAISSANCE TECHNOLOGIES LLC (18.9K shares), STATE STREET CORP (12.2K shares), UBS Group AG (3.91K shares), OSAIC HOLDINGS, INC. (1.73K shares), JPMORGAN CHASE & CO (439 shares), PSI Advisors, LLC (399 shares), and WELLS FARGO & COMPANY/MN (304 shares).
This table shows the top 11 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.